BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 14584822)

  • 1. Neuritic alterations and neural system dysfunction in Alzheimer's disease and dementia with Lewy bodies.
    Klucken J; McLean PJ; Gomez-Tortosa E; Ingelsson M; Hyman BT
    Neurochem Res; 2003 Nov; 28(11):1683-91. PubMed ID: 14584822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies.
    Hashimoto M; Masliah E
    Neurochem Res; 2003 Nov; 28(11):1743-56. PubMed ID: 14584828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
    Marui W; Iseki E; Kato M; Akatsu H; Kosaka K
    Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Factors Mediating Neural Cell Plasticity Changes in Dementia Brain Diseases.
    Kozubski W; Ong K; Waleszczyk W; Zabel M; Dorszewska J
    Neural Plast; 2021; 2021():8834645. PubMed ID: 33854544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated microglial cells and complement factors are unrelated to cortical Lewy bodies.
    Rozemuller AJ; Eikelenboom P; Theeuwes JW; Jansen Steur EN; de Vos RA
    Acta Neuropathol; 2000 Dec; 100(6):701-8. PubMed ID: 11078223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.
    Walker L; McAleese KE; Thomas AJ; Johnson M; Martin-Ruiz C; Parker C; Colloby SJ; Jellinger K; Attems J
    Acta Neuropathol; 2015 May; 129(5):729-48. PubMed ID: 25758940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies.
    Wetering JV; Geut H; Bol JJ; Galis Y; Timmermans E; Twisk JWR; Hepp DH; Morella ML; Pihlstrom L; Lemstra AW; Rozemuller AJM; Jonkman LE; van de Berg WDJ
    Acta Neuropathol Commun; 2024 May; 12(1):73. PubMed ID: 38715119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration.
    Chai YL; Chong JR; Weng J; Howlett D; Halsey A; Lee JH; Attems J; Aarsland D; Francis PT; Chen CP; Lai MKP
    Brain Pathol; 2019 Jan; 29(1):63-74. PubMed ID: 30051532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal α-Synuclein in Dementia with Lewy Bodies Contributes to Memory Impairment and Is Consistent with Spread of Pathology.
    Adamowicz DH; Roy S; Salmon DP; Galasko DR; Hansen LA; Masliah E; Gage FH
    J Neurosci; 2017 Feb; 37(7):1675-1684. PubMed ID: 28039370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathological investigation of the hypometabolic regions on positron emission tomography with [18F] fluorodeoxyglucose in patients with dementia with Lewy bodies.
    Kasanuki K; Iseki E; Fujishiro H; Yamamoto R; Higashi S; Minegishi M; Togo T; Katsuse O; Uchikado H; Furukawa Y; Hino H; Kosaka K; Sato K; Arai H
    J Neurol Sci; 2012 Mar; 314(1-2):111-9. PubMed ID: 22041339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
    Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
    J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.
    Culvenor JG; McLean CA; Cutt S; Campbell BC; Maher F; Jäkälä P; Hartmann T; Beyreuther K; Masters CL; Li QX
    Am J Pathol; 1999 Oct; 155(4):1173-81. PubMed ID: 10514400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation.
    Arai Y; Yamazaki M; Mori O; Muramatsu H; Asano G; Katayama Y
    Brain Res; 2001 Jan; 888(2):287-296. PubMed ID: 11150486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Transforming Growth Factor β2 in the Neocortex of Alzheimer's Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Aβ42 Load.
    Chong JR; Chai YL; Lee JH; Howlett D; Attems J; Ballard CG; Aarsland D; Francis PT; Chen CP; Lai MK
    J Alzheimers Dis; 2017; 56(1):157-166. PubMed ID: 27911312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies.
    Campbell BC; Li QX; Culvenor JG; Jäkälä P; Cappai R; Beyreuther K; Masters CL; McLean CA
    Neurobiol Dis; 2000 Jun; 7(3):192-200. PubMed ID: 10860784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lewy body pathology in Alzheimer's disease.
    Kotzbauer PT; Trojanowsk JQ; Lee VM
    J Mol Neurosci; 2001 Oct; 17(2):225-32. PubMed ID: 11816795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein inclusions in Alzheimer and Lewy body diseases.
    Mukaetova-Ladinska EB; Hurt J; Jakes R; Xuereb J; Honer WG; Wischik CM
    J Neuropathol Exp Neurol; 2000 May; 59(5):408-17. PubMed ID: 10888371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
    Bayer TA; Jäkälä P; Hartmann T; Havas L; McLean C; Culvenor JG; Li QX; Masters CL; Falkai P; Beyreuther K
    Neurosci Lett; 1999 May; 266(3):213-6. PubMed ID: 10465711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathological investigation of hypocretin expression in brains of dementia with Lewy bodies.
    Kasanuki K; Iseki E; Kondo D; Fujishiro H; Minegishi M; Sato K; Katsuse O; Hino H; Kosaka K; Arai H
    Neurosci Lett; 2014 May; 569():68-73. PubMed ID: 24704327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant Overlap of α-Synuclein, Amyloid-β, and Phospho-Tau Pathologies in Neuropathological Diagnosis of Lewy-related Pathology: Evidence from China Human Brain Bank.
    Cong C; Zhang W; Qian X; Qiu W; Ma C
    J Alzheimers Dis; 2021; 80(1):447-458. PubMed ID: 33554920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.